Table 2.
Kaplan-Meier univariate analysis: DFS and OS in patients without metastasis (%)
| DFS (3.5 years) | P value | OS (4 years) | P value | |
|---|---|---|---|---|
| Stage (I, II, III) | 82 vs. 76 vs. 56 | 0.02 | 88 vs. 76 vs. 76 | 0.06 |
| Age (<70 vs. >70 years) | 78 vs. 62 | 0.008 | 88 vs. 67 | <0.001 |
| Location (right vs. left) | 78 vs. 64 | 0.06 | 79 vs. 75 | 0.09 |
| RAS (mut. vs. wt) | 63 vs. 78 | 0.02 | 70 vs. 80 | 0.045 |
| BRAF (mut. vs. wt) | 72 vs. 73 | 0.83 | 65 vs. 79 | 0.41 |
| MMR (def. vs. pro.) | 73 vs. 70 | 0.92 | 78.3 vs. 78.2 | 0.77 |
Median not reached in survival outcomes (DFS or OS) and presented as the proportion of patients who did not relapse or are alive, at a median follow-up of 48 months. Mut., mutated; wt, wild type; def., deficient; pro., proficient.